Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study.

Johnston AW, Longo TA, Davis LG, Zapata D, Freedland SJ, Routh JC.

Int Braz J Urol. 2020 Jan-Feb;46(1):42-52. doi: 10.1590/S1677-5538.IBJU.2019.0225.

2.

Heated Intravesical Chemotherapy: Biology and Clinical Utility.

Tan WP, Longo TA, Inman BA.

Urol Clin North Am. 2020 Feb;47(1):55-72. doi: 10.1016/j.ucl.2019.09.008. Review.

PMID:
31757301
3.

Dietary patterns and health-related quality of life in bladder cancer survivors.

Gopalakrishna A, Chang A, Longo TA, Fantony JJ, Harrison MR, Wischmeyer PE, Inman BA.

Urol Oncol. 2018 Oct;36(10):469.e21-469.e29. doi: 10.1016/j.urolonc.2018.06.001. Epub 2018 Aug 17.

PMID:
30126776
4.

Over half of contemporary clinical Gleason 8 on prostate biopsy are downgraded at radical prostatectomy.

Qi R, Foo WC, Ferrandino MN, Davis LG, Sekar S, Longo TA, Jibara G, Han T, Gokhan I, Moul JW.

Can J Urol. 2017 Oct;24(5):8982-8989.

PMID:
28971784
5.

Physical activity patterns and associations with health-related quality of life in bladder cancer survivors.

Gopalakrishna A, Longo TA, Fantony JJ, Harrison MR, Inman BA.

Urol Oncol. 2017 Sep;35(9):540.e1-540.e6. doi: 10.1016/j.urolonc.2017.04.016. Epub 2017 May 17.

6.

Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancer.

Fantony JJ, Longo TA, Gopalakrishna A, Owusu R, Lance RS, Foo WC, Inman BA, Abern MR.

Cancer Biomark. 2017;18(4):381-387. doi: 10.3233/CBM-160261.

PMID:
28106542
7.

Anticipatory Positive Urine Tests for Bladder Cancer.

Gopalakrishna A, Fantony JJ, Longo TA, Owusu R, Foo WC, Dash R, Denton BT, Inman BA.

Ann Surg Oncol. 2017 Jun;24(6):1747-1753. doi: 10.1245/s10434-016-5763-5. Epub 2017 Jan 10.

PMID:
28074325
8.

Atezolizumab: A PD-L1-Blocking Antibody for Bladder Cancer.

Inman BA, Longo TA, Ramalingam S, Harrison MR.

Clin Cancer Res. 2017 Apr 15;23(8):1886-1890. doi: 10.1158/1078-0432.CCR-16-1417. Epub 2016 Nov 30. Review.

9.

The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient.

Gopalakrishna A, Longo TA, Fantony JJ, Owusu R, Foo WC, Dash R, Inman BA.

BMC Urol. 2016 Jun 13;16(1):30. doi: 10.1186/s12894-016-0147-5.

10.

High rates of venous thromboembolic events in patients undergoing systemic therapy for urothelial carcinoma: A systematic review and meta-analysis.

Gopalakrishna A, Longo TA, Fantony JJ, Doshi U, Harrison MR, Van Noord M, Inman BA.

Urol Oncol. 2016 Sep;34(9):407-14. doi: 10.1016/j.urolonc.2016.05.009. Epub 2016 Jun 4. Review.

11.

A systematic review of regional hyperthermia therapy in bladder cancer.

Longo TA, Gopalakrishna A, Tsivian M, Van Noord M, Rasch CR, Inman BA, Geijsen ED.

Int J Hyperthermia. 2016 Jun;32(4):381-9. doi: 10.3109/02656736.2016.1157903. Epub 2016 May 1. Review.

12.

Lifestyle factors and health-related quality of life in bladder cancer survivors: a systematic review.

Gopalakrishna A, Longo TA, Fantony JJ, Van Noord M, Inman BA.

J Cancer Surviv. 2016 Oct;10(5):874-82. doi: 10.1007/s11764-016-0533-8. Epub 2016 Mar 21. Review.

13.

Ciliopathy-associated gene Cc2d2a promotes assembly of subdistal appendages on the mother centriole during cilia biogenesis.

Veleri S, Manjunath SH, Fariss RN, May-Simera H, Brooks M, Foskett TA, Gao C, Longo TA, Liu P, Nagashima K, Rachel RA, Li T, Dong L, Swaroop A.

Nat Commun. 2014 Jun 20;5:4207. doi: 10.1038/ncomms5207.

Supplemental Content

Loading ...
Support Center